Physician profile
Judith A Deckert
NPI 1548249352
$3,140.52
in general payments reported to CMS, 2019-2025
12 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,002 · 2022: $435 · 2023: $301 · 2024: $262 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $703.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $1,600.00 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $280.08 | 2021-2024 | Lifevest |
| Amgen INC. | $279.33 | 2021-2023 | Repatha |
| Novartis Pharmaceuticals Corporation | $214.99 | 2023-2025 | |
| Abbott Laboratories | $203.21 | 2021-2024 | Cardiomems |
| Astrazeneca Pharmaceuticals LP | $200.04 | 2023-2024 | Lokelma, Farxiga |
| Novo Nordisk INC | $123.70 | 2025 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.17 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $72.85 | 2021 | |
| Amarin Pharma, INC. | $19.76 | 2021 | |
| Boston Scientific Corporation | $19.43 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $17.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Deckert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.